|
IT1264696B1
(it)
*
|
1993-07-09 |
1996-10-04 |
Applied Pharma Res |
Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
|
|
DE19524753A1
(de)
*
|
1995-07-07 |
1997-01-23 |
Lohmann Therapie Syst Lts |
Schichttablette zur kontrollierten Freisetzung von Wirkstoffen
|
|
US5783212A
(en)
*
|
1996-02-02 |
1998-07-21 |
Temple University--of the Commonwealth System of Higher Education |
Controlled release drug delivery system
|
|
IT1282650B1
(it)
*
|
1996-02-19 |
1998-03-31 |
Jagotec Ag |
Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
|
|
GB9611328D0
(en)
*
|
1996-05-31 |
1996-08-07 |
Zeneca Ltd |
Pharmaceutical compositions
|
|
EP0951279A1
(en)
*
|
1997-01-10 |
1999-10-27 |
Abbott Laboratories |
Tablet for the controlled release of active agents
|
|
IN186245B
(el)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
|
IT1295271B1
(it)
*
|
1997-10-03 |
1999-05-04 |
Chiesi Farma Spa |
Monolita contenente uno o piu'farmaci costituito da tre strati a meccanismo di rilascio differenziato
|
|
US6337091B1
(en)
*
|
1997-10-27 |
2002-01-08 |
Temple University - Of The Commonwealth System Of Higher Education |
Matrix for controlled delivery of highly soluble pharmaceutical agents
|
|
US6110500A
(en)
*
|
1998-03-25 |
2000-08-29 |
Temple University |
Coated tablet with long term parabolic and zero-order release kinetics
|
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
|
US6245913B1
(en)
|
1999-06-30 |
2001-06-12 |
Wockhardt Europe Limited |
Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
|
|
ES2270982T3
(es)
|
2000-02-04 |
2007-04-16 |
Depomed, Inc. |
Forma de dosificacion de nucleo y carcasa que se aproxima a una liberacion del farmaco de orden cero.
|
|
DE10031043A1
(de)
*
|
2000-06-26 |
2002-02-14 |
Bayer Ag |
Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
|
|
KR100685945B1
(ko)
|
2000-12-29 |
2007-02-23 |
엘지.필립스 엘시디 주식회사 |
액정표시장치 및 그 제조방법
|
|
US20030104052A1
(en)
*
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
US20030091630A1
(en)
*
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
US20030152622A1
(en)
*
|
2001-10-25 |
2003-08-14 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral diuretic
|
|
CA2409552A1
(en)
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
ITMI20012481A1
(it)
*
|
2001-11-23 |
2003-05-23 |
Univ Parma |
Sistemi modulari per il rilascio controllato di sostanza a controllo spaziale e temporale
|
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
|
US6852238B2
(en)
*
|
2002-08-29 |
2005-02-08 |
Steller Technology Company |
Layered tablet water treatment compositions and method of use
|
|
US7309444B2
(en)
*
|
2002-08-29 |
2007-12-18 |
Stellar Technology Company |
Layered tablet water treatment compositions and method of use
|
|
EP1617832B1
(en)
|
2003-04-29 |
2008-03-12 |
Orexigen Therapeutics, Inc. |
Compositions for affecting weight loss
|
|
US20040241234A1
(en)
*
|
2003-06-02 |
2004-12-02 |
Alpharma, Inc. |
Controlled release press-coated formulations of water-soluble active agents
|
|
US20050013863A1
(en)
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
|
KR20070043806A
(ko)
*
|
2004-07-29 |
2007-04-25 |
사노피-아벤티스 |
pH에 매우 의존적인 용해도를 가지는 활성 성분의 제어방출을 위한 약제학적 다층 정제
|
|
US20060024368A1
(en)
*
|
2004-07-30 |
2006-02-02 |
Reza Fassihi |
Compressed composite delivery system for release-rate modulation of bioactives
|
|
JP2008509144A
(ja)
*
|
2004-08-04 |
2008-03-27 |
アルザ・コーポレーシヨン |
上昇するゼロ次放出パターンを示す持続薬剤放出組成物、そのような組成物を製造する方法
|
|
BRPI0518125A
(pt)
*
|
2004-11-19 |
2008-10-28 |
Smithkline Beecham Corp |
produto farmacêutico
|
|
US9029427B2
(en)
*
|
2005-11-11 |
2015-05-12 |
Asahi Kasei Chemicals Corporation |
Controlled release solid preparation
|
|
PL1954249T3
(pl)
|
2005-11-18 |
2015-12-31 |
Glaxo Group Ltd |
Urządzenie i sposób zespalania produktów farmaceutycznych oraz podobnych do farmaceutycznych
|
|
US8231902B2
(en)
*
|
2005-11-18 |
2012-07-31 |
Accu-Break Technologies, Inc. |
Segmented pharmaceutical dosage forms
|
|
CN101370488B
(zh)
|
2005-11-22 |
2012-07-18 |
奥雷西根治疗公司 |
增加胰岛素敏感性的组合物
|
|
US8916195B2
(en)
|
2006-06-05 |
2014-12-23 |
Orexigen Therapeutics, Inc. |
Sustained release formulation of naltrexone
|
|
MX2008016349A
(es)
*
|
2006-06-19 |
2009-01-28 |
Accu Break Technologies Inc |
Formas segmentadas de dosificacion farmaceutica.
|
|
KR20170077291A
(ko)
|
2006-11-09 |
2017-07-05 |
오렉시젠 세러퓨틱스 인크. |
단위 용량 팩키지
|
|
DK2089005T3
(da)
*
|
2006-11-09 |
2010-07-19 |
Orexigen Therapeutics Inc |
Lagdelte farmaceutiske formuleringer omfattende et hurtigt opløsende mellemlag
|
|
US20100322978A1
(en)
*
|
2006-12-27 |
2010-12-23 |
Fujifilm Corporation |
Medical composition
|
|
KR100885029B1
(ko)
*
|
2007-02-07 |
2009-02-23 |
지엘팜텍 주식회사 |
경구투여용 서방성 삼중정제
|
|
ES2841379T3
(es)
|
2007-03-13 |
2021-07-08 |
Jds Therapeutics Llc |
Procedimientos y composiciones para la liberación sostenida de cromo
|
|
WO2009002867A2
(en)
|
2007-06-26 |
2008-12-31 |
Nutrition 21, Inc. |
Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
|
|
US20130079749A1
(en)
*
|
2007-08-29 |
2013-03-28 |
Advanced Bionics, Llc |
Modular Drug Delivery System for Minimizing Trauma During and After Insertion of a Cochlear Lead
|
|
EP2359807B1
(en)
*
|
2008-02-04 |
2017-07-26 |
Ferring B.V. |
Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
|
|
WO2009118763A1
(en)
*
|
2008-03-28 |
2009-10-01 |
Panacea Biotec Limited |
Multilayered pharmaceutical compositions and processes thereof
|
|
WO2009158114A1
(en)
|
2008-05-30 |
2009-12-30 |
Orexigen Therapeutics, Inc. |
Methods for treating visceral fat conditions
|
|
CA2728856A1
(en)
*
|
2008-06-16 |
2010-01-14 |
Appian Labs, Llc |
Composition and method of preparation of release systems for constant (zero-order) release of active agents
|
|
DK2328561T3
(en)
*
|
2008-08-19 |
2016-02-08 |
Adcock Ingram Intellectual Property Pty Ltd |
Rate modulated administration of drugs from a three-layered tablet containing tramadol, diclofenac, paracetamol
|
|
EP2163240A1
(en)
|
2008-09-12 |
2010-03-17 |
Universita' Degli Studi Di Genova |
A method for the production of bioadhesive compact matrices
|
|
WO2010048478A2
(en)
*
|
2008-10-23 |
2010-04-29 |
Appian Labs, Llc |
Tablets and discs with compartments with two or more drugs for release at certain intervals and with specific rates
|
|
BRPI0906820A2
(pt)
*
|
2009-12-21 |
2013-07-30 |
Inst Presbiteriano Mackenzie |
matriz cerÂmica para incorporar fÁrmacos de liberaÇço controlada, comprimido, mÉtodo para obtenÇço da matriz cerÂmica e mÉtodo para produzir um comprimido
|
|
MX344303B
(es)
|
2010-01-11 |
2016-12-13 |
Orexigen Therapeutics Inc |
Metodos para proveer terapia de perdida de peso en pacientes con depresion mayor.
|
|
HUE034955T2
(en)
|
2010-12-22 |
2018-03-28 |
Purdue Pharma Lp |
Encased tamper resistant controlled release dosage forms
|
|
PH12013501345A1
(en)
|
2010-12-23 |
2022-10-24 |
Purdue Pharma Lp |
Tamper resistant solid oral dosage forms
|
|
US9622979B2
(en)
*
|
2011-06-29 |
2017-04-18 |
Sun Pharmaceutical Industries Limited |
Multilayered dosage form
|
|
TW201311296A
(zh)
*
|
2011-07-01 |
2013-03-16 |
Gelita Ag |
新穎明膠膠囊組合物及其製備方法
|
|
US20140377347A1
(en)
|
2012-01-23 |
2014-12-25 |
Ranbaxy Laboratories Limited |
In-situ multilayered tablet technology
|
|
CN110893181A
(zh)
|
2012-06-06 |
2020-03-20 |
纳丙药业有限责任公司 |
治疗超重和肥胖症的方法
|
|
MX2015010041A
(es)
|
2013-02-05 |
2015-10-30 |
Purdue Pharma Lp |
Formulacion farmaceuticas resistentes a la alteracion.
|
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
|
CA3014308A1
(en)
|
2016-02-11 |
2017-08-17 |
Nutrition 21, Llc |
Chromium containing compositions for improving health and fitness
|